The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
PI3K/Akt/mTOR pathway inhibitors enhance radiosensitivity in radioresistant prostate cancer cells through inducing apoptosis, reducing autophagy, suppressing NHEJ and HR repair pathways
Open accessAbstract
The PI3K/Akt/mTOR pathway has a central role in cancer metastasis and radiotherapy. To develop effective therapeutics to improve radiosensitivity, understanding the possible pathways of radioresistance involved and the effects of a combination of the PI3K/Akt/mTOR inhibitors with radiotherapy on prostate cancer (CaP) radioresistant cells is needed. We found that compared with parent CaP cells, CaP-radioresistant cells demonstrated G0/G1 and S phase arrest, activation of cell cycle check point, autophagy and DNA repair pathway proteins, and inactivation of apoptotic proteins. We also demonstrated that compared with combination of single PI3K or mTOR inhibitors (BKM120 or Rapamycin) and radiation, low-dose of dual PI3K/mTOR inhibitors (BEZ235 or PI103) combined with radiation greatly improved treatment efficacy by repressing colony formation, inducing more apoptosis, leading to the arrest of the G2/M phase, increased double-strand break levels and less inactivation of cell cycle check point, autophagy and non-homologous end joining (NHEJ)/homologous recombination (HR) repair pathway proteins in CaP-radioresistant cells. This study describes the possible pathways associated with CaP radioresistance and demonstrates the putative mechanisms of the radiosensitization effect in CaP-resistant cells in the combination treatment. The findings from this study suggest that the combination of dual PI3K/Akt/mTOR inhibitors (BEZ235 or PI103) with radiotherapy is a promising modality for the treatment of CaP to overcome radioresistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The PI3K Pathway As Drug Target in Human Cancer
Courtney, K. D., Corcoran, R. B., & Engelman, J. A. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.3641 · Cited by 1,237
Sensing and repairing DNA double-strand breaks
Jackson, S. P. (2002) · Carcinogenesis · doi:10.1093/carcin/23.5.687 · Cited by 1,128
Role of cell cycle in mediating sensitivity to radiotherapy
Pawlik, T. M., & Keyomarsi, K. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.03.005 · Cited by 1,102
The mTOR Signalling Pathway in Human Cancer
Pópulo, H., Lopes, J. M., & Soares, P. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13021886 · Cited by 830
Serra, V., Markman, B., Scaltriti, M., Eichhorn, P. J. A., Valero, V., Guzman, M., Botero, M. L., Llonch, E., Atzori, F., Di Cosimo, S., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1385 · Cited by 787
Pathways governing G1/S transition and their response to DNA damage
Bartek, J., & Lukas, J. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02114-7 · Cited by 471
Chang, L., Graham, P. H., Hao, J., Ni, J., Bucci, J., Cozzi, P. J., Kearsley, J. H., & Li, Y. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.407 · Cited by 377
Self-citationCell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21.
Li, Y., Jenkins, C. W., Nichols, M. A., & Xiong, Y. (1994) · PubMed · Cited by 358
Self-citationPharmacologic Characterization of a Potent Inhibitor of Class I Phosphatidylinositide 3-Kinases
Raynaud, F. I., Eccles, S., Clarke, P. A., Hayes, A., Nutley, B., Alix, S., Henley, A., Di-Stefano, F., Ahmad, Z., Guillard, S., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4615 · Cited by 352
MicroRNA 23b Regulates Autophagy Associated With Radioresistance of Pancreatic Cancer Cells
Wang, P., Zhang, J., Zhang, L., Zhu, Z., Fan, J., Chen, L., Zhuang, L., Luo, J., Chen, H., Liu, L., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.07.048 · Cited by 234
Wallin, J. J., Edgar, K. A., Guan, J., Berry, M., Prior, W. W., Lee, L., Lesnick, J. D., Lewis, C., Nonomiya, J., Pang, J., et al. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0446 · Cited by 229
Ni, J., Cozzi, P., Hao, J., Beretov, J., Chang, L., Duan, W., Shigdar, S., Delprado, W., Graham, P., Bucci, J., et al. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.09.008 · Cited by 195
Self-citationVo, B. T., Morton, D., Komaragiri, S., Millena, A. C., Leath, C., & Khan, S. A. (2013) · Endocrinology · doi:10.1210/en.2012-2074 · Cited by 192
Emerging roles of radioresistance in prostate cancer metastasis and radiation therapy
Chang, L., Graham, P., Hao, J., Bucci, J. A., Cozzi, P. J., Kearsley, J. H., & Li, Y. (2014) · Cancer and Metastasis Reviews · doi:10.1007/s10555-014-9493-5 · Cited by 129
Self-citationVertical inhibition of the PI3K/Akt/mTOR pathway for the treatment of osteoarthritis
Chen, J., Crawford, R., & Xiao, Y. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24362 · Cited by 128
Autophagy in tumorigenesis and cancer therapy: Dr. Jekyll or Mr. Hyde?
Zhou, S., Zhao, L., Kuang, M., Zhang, B., Liang, Z., Yi, T., Wei, Y., & Zhao, X. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.02.017 · Cited by 125
Use of γH2AX and Other Biomarkers of Double-Strand Breaks During Radiotherapy
Sak, A., & Stuschke, M. (2010) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2010.05.004 · Cited by 118
PI3K inhibitors for cancer treatment: where do we stand?
Maira, S.-M., Stauffer, F., Schnell, C., & García-Echeverría, C. (2009) · Biochemical Society Transactions · doi:10.1042/bst0370265 · Cited by 113
The non-coding transcriptome as a dynamic regulator of cancer metastasis
Crea, F., Clermont, P., Parolia, A., Wang, Y. Z., & Helgason, C. D. (2013) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9455-3 · Cited by 101
p53, cyclin-dependent kinase and abnormal amplification of centrosomes
Fukasawa, K. (2008) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2008.04.002 · Cited by 85
Coen, J. J., Bae, K., Zietman, A. L., Patel, B., Shipley, W. U., Slater, J. D., & Rossi, C. J. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.06.047 · Cited by 71
Chang, Z., Shi, G., JIN, J., Huatao, G., Guo, X., LUO, F., Yu-guo, S., & Jia, X. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1351 · Cited by 67
Vora, S. A., Wong, W. W., Schild, S. E., Ezzell, G. A., Andrews, P. E., Ferrigni, R. G., & Swanson, S. K. (2013) · The Journal of Urology · doi:10.1016/j.juro.2013.02.012 · Cited by 50
Amrein, L., Shawi, M., Grenier, J. M., Aloyz, R. S., & Panasci, L. (2012) · International Journal of Cancer · doi:10.1002/ijc.27989 · Cited by 44
External beam radiation therapy for prostate cancer
Horwitz, E. M., & Hanks, G. E. (2000) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.50.6.349 · Cited by 29
Chao, H., Wang, L., Hao, J., Ni, J., Chang, L., Graham, P., Kearsley, J. H., & Li, Y. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.08.035 · Cited by 29
Self-citationCancer, stem cells and cancer stem cells: old ideas, new developments
Ghaffari, S. (2011) · F1000 Medicine Reports · doi:10.3410/m3-23 · Cited by 25
Cited by
Targeting PI3K/Akt signal transduction for cancer therapy
He, Y., Sun, M. M., Zhang, G. G., Yang, J., Chen, K. S., Xu, W. W., & Li, B. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00828-5 · Cited by 1,892
Huang, R., & Zhou, P.-K. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00648-7 · Cited by 907
Orth, M., Metzger, P., Gerum, S., Mayerle, J., Schneider, G., Belka, C., Schnurr, M., & Lauber, K. (2019) · Radiation Oncology · doi:10.1186/s13014-019-1345-6 · Cited by 490
Role of metabolism in cancer cell radioresistance and radiosensitization methods
Tang, L., Wei, F., Wu, Y., He, Y., Shi, L., Xiong, F., Gong, Z., Guo, C., Li, X., Deng, H., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0758-7 · Cited by 409
Self-citationLiu, Y., Zheng, C., Huang, Y., He, M., Xu, W. W., & Li, B. (2021) · MedComm · doi:10.1002/mco2.55 · Cited by 387
Metadata
- Authors
- Chang, L., Graham, P. H., Hao, J., Ni, J., Bucci, J., Cozzi, P. J., Kearsley, J. H., & Li, Y.
- Venue
- Cell Death & Disease
- Published
- 2014-10-02
- Volume
- 5
- Issue
- 10
- Pages
- e1437-e1437
- ISSN
- 2041-4889 (ISSN-L)
- OpenAlex
- W1969043065
- Cited by
- 304
- References
- 27
- FWCI
- 9.37
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.